terazosin
- Product NDC
- 50090-7851
- 11-digit product format
- 500907851
- Labeler code
- 50090
- Product ID
- 50090-7851_bba25161-4506-4e35-a98a-deff97b5d23f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA075614
- Marketing category
- ANDA
- Marketing start
- 2021-04-30
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- terazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERAZOSIN HYDROCHLORIDE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D32S14F082 |
| Rxcui | 313215 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-7851-0 | terazosin | 30 in 1 BOTTLE | CAPSULE | 30 | | 1 |
| 50090-7851-1 | terazosin | 90 in 1 BOTTLE | CAPSULE | 90 | | 1 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-7851-0 | 50090785100 | 30 CAPSULE in 1 BOTTLE (50090-7851-0) | 30 capsule | 2026-01-08 | No | No | Historical |
| 50090-7851-1 | 50090785101 | 90 CAPSULE in 1 BOTTLE (50090-7851-1) | 90 capsule | 2026-01-08 | No | No | Historical |